Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Saturday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Up 7.2 %

ENZ stock opened at $0.49 on Friday. Enzo Biochem has a 52 week low of $0.41 and a 52 week high of $1.30. The company has a fifty day simple moving average of $0.58 and a two-hundred day simple moving average of $0.89.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Hedge Funds Weigh In On Enzo Biochem

Institutional investors have recently bought and sold shares of the business. BBR Partners LLC bought a new position in Enzo Biochem during the third quarter valued at $112,000. Lepercq Multi Asset Fund bought a new stake in shares of Enzo Biochem in the 4th quarter worth about $88,000. Mink Brook Asset Management LLC bought a new stake in shares of Enzo Biochem in the 4th quarter worth about $577,000. Wittenberg Investment Management Inc. lifted its holdings in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after acquiring an additional 70,400 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in shares of Enzo Biochem in the 4th quarter worth about $35,000. Institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.